Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Cytopenias”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00005622
What this trial is testing

Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMultiple Myeloma and Malignant Plasma Cell Neoplasms+2 more
H. Lee Moffitt Cancer Center and Research Institute 72
Testing effectiveness (Phase 2)Study completedNCT01822691
What this trial is testing

Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
H. Lee Moffitt Cancer Center and Research Institute 15
Not applicableStudy completedNCT02922543
What this trial is testing

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Who this might be right for
Multiple Myeloma
Celgene 361
Very early researchLooking for participantsNCT07174843
What this trial is testing

An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases

Who this might be right for
Idiopathic Inflammatory Myopathies(IIM)Immune Thrombocytopenia(ITP)Systemic Lupus Erythematosus(SLE)
Shanghai Cell Therapy Group Co.,Ltd 20
Early research (Phase 1)Looking for participantsNCT06787989
What this trial is testing

BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases

Who this might be right for
Refractory Immune Cytopenia
iCell Gene Therapeutics 20
Testing effectiveness (Phase 2)Looking for participantsNCT06794008
What this trial is testing

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusInflammatory MyopathySystemic Sclerosis (SSc)+6 more
Peking University People's Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00113789
What this trial is testing

Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer

Who this might be right for
Ovarian Cancer
Amgen 21
Testing effectiveness (Phase 2)Study completedNCT01667263
What this trial is testing

The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia

Who this might be right for
Autoimmune Thrombocytopenia
Peking University People's Hospital 130
Very early researchUnknownNCT05930314
What this trial is testing

CNCT19 Cell Injection for Refractory Systemic Lupus Erythematosus

Who this might be right for
Refractory Systemic Lupus ErythematosusLupus NephritisImmune Thrombocytopenia
Peking Union Medical College Hospital 12
Post-approval studies (Phase 4)Ended earlyNCT00421187
What this trial is testing

Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics

Who this might be right for
Febrile Neutropenia
Gilead Sciences 20
Early research (Phase 1)Study completedNCT00988715
What this trial is testing

Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

Who this might be right for
Chronic Myelomonocytic LeukemiaMyelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic Syndrome+6 more
Fred Hutchinson Cancer Center 17
Large-scale testing (Phase 3)UnknownNCT00002926
What this trial is testing

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC 80
Testing effectiveness (Phase 2)Study completedNCT00002800
What this trial is testing

Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesNeutropenia
Memorial Sloan Kettering Cancer Center 60
Not applicableStudy completedNCT01971684
What this trial is testing

ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP

Who this might be right for
Immune Thrombocytopenia
Boston Children's Hospital 120
Not applicableEnded earlyNCT02050581
What this trial is testing

A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone

Who this might be right for
Idiopathic Thrombocytopenia Purpura
Weill Medical College of Cornell University 72
Very early researchLooking for participantsNCT06888960
What this trial is testing

Safety Study of CC312 in Autoimmune Disease Patients

Who this might be right for
Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathy (IIM)Systemic Sclerosis (SSc)+3 more
CytoCares Inc 18
Testing effectiveness (Phase 2)Study completedNCT01891994
What this trial is testing

Extended Dosing With Eltrombopag for Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia (SAA)
National Heart, Lung, and Blood Institute (NHLBI) 40
Not applicableStudy completedNCT00290641
What this trial is testing

Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+1 more
Masonic Cancer Center, University of Minnesota 68
Not applicableWithdrawnNCT06813157
What this trial is testing

Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia

Who this might be right for
ITP - Immune Thrombocytopenia
Guangzhou Bio-gene Technology Co., Ltd
Testing effectiveness (Phase 2)WithdrawnNCT01194167
What this trial is testing

Study of Eltrombopag in Platelet Refractory Thrombocytopenia

Who this might be right for
Thrombocytopenia
University of Cincinnati
Next Page